共 308 条
[1]
O’Gara PT(2013)2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 127 e362-e425
[2]
Kushner FG(2014)2014 AHA/ACC Guideline for the Management of Patients With Non ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 64 S0735-S1097
[3]
Ascheim DD(2003)Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both N Engl J Med 349 1893-1906
[4]
Casey DE(2008)Telmisartan, ramipril, or both in patients at high risk for vascular events N Engl J Med 358 1547-1559
[5]
Chung MK(2013)Not just numbers, but years of science: putting the ACE inhibitor-ARB meta-analyses into context Int J Cardiol 166 286-288
[6]
de Lemos JA(2014)Comparative assessment of angiotensin II type 1 receptor blockers in the treatment of acute myocardial infarction: surmountable vs. insurmountable antagonist Int J Cardiol 170 291-297
[7]
Ettinger SM(2013)2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards) Circulation 127 1052-1089
[8]
Fang JC(1976)Prediction of creatinine clearance from serum creatinine Nephron 16 31-41
[9]
Fesmire FM(2011)MatchIt: nonparametric preprocessing for parametric causal inference J Stat Softw 42 1-28
[10]
Franklin BA(2004)A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry JAMA 291 2727-2733